BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Mar 01, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ADL5747: Phase IIa started

In January, Adolor and Pfizer began a double-blind, placebo-controlled, crossover Phase IIa trial to compare 150 mg ADL5747 given twice daily vs. Lyrica pregablin...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >